OPRM1 - mu opioid receptor (pharmacogenetics)
This test is available for the following conditions:
- Conditions > Pharmacogenetics > Naltrexone metabolism (pharmacogenetics)
Complete analysis & Targeted analysis: 1.5 week
- Targeted analysis of one or more mutations
Genetic analysis of the c.118A>G variant in OPRM1.
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane